Business · 10/12/2003Updated: 10/17/2026 · 1 min read
FDA Announces Availability of Guidance Document for Blood and Blood Components
Summary
The Food and Drug Administration (FDA) has released a guidance document that recognizes a 2002 circular as acceptable for use by blood and blood component manufacturers, aiming to help them comply with FDA labeling regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →